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Aim: Skeletal muscle subjected to hypoxia followed by reoxygenation is susceptible to
injury and subsequent muscle function decline. This phenomenon can be observed
in the diaphragm during strenuous exercise or in pulmonary diseases such as
chronic obstructive pulmonary diseases (COPD). Previous studies have shown that
PO2 cycling or hypoxic preconditioning (HPC), as it can also be referred to as,
protects muscle function via mechanisms involving reactive oxygen species (ROS).
However, this HPC protection has not been fully elucidated in aged pulmonary TNF-α
overexpressing (Tg+) mice (a COPD-like model). We hypothesize that HPC can exert
protection on the diaphragms of Tg+ mice during reoxygenation through pathways
involving ROS/phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/extracellular
signal regulated kinase (ERK), as well as the downstream activation of mitochondrial
ATP-sensitive potassium channel (mitoKATP) and inhibition of mitochondrial permeability
transition pore (mPTP).
Methods: Isolated Tg+ diaphragm muscle strips were pre-treated with inhibitors for
ROS, PI3K, Akt, ERK, or a combination of mitoKATP inhibitor and mPTP opener,
respectively, prior to HPC. Another two groups of muscles were treated with either
mitoKATP activator or mPTP inhibitor without HPC. Muscles were treated with 30-min
hypoxia, followed by 15-min reoxygenation. Data were analyzed by multi-way ANOVA
and expressed as means ± SE.
Results: Muscle treated with HPC showed improved muscle function during
reoxygenation (n = 5, p < 0.01). Inhibition of ROS, PI3K, Akt, or ERK abolished the
protective effect of HPC. Simultaneous inhibition of mitoKATP and activation of mPTP
also diminished HPC effects. By contrast, either the opening of mitoKATP channel or
the closure of mPTP provided a similar protective effect to HPC by alleviating muscle
function decline, suggesting that mitochondria play a role in HPC initiation (n = 5;
p < 0.05).
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Conclusion: Hypoxic preconditioning may protect respiratory skeletal muscle function
in Tg+ mice during reoxygenation through redox-sensitive signaling cascades and
regulations of mitochondrial channels.
Keywords: COPD, diaphragm, hypoxia, preconditioning, reactive oxygen species
INTRODUCTION
Chronic obstructive pulmonary diseases (COPD) are the fourth
leading cause of death in the world, with particularly high
prevalence among the elderly population (Cazzola et al.,
2010; Huang et al., 2013). The diaphragm shows mechanical
overloading in COPD, resulting in progressive muscle weakness
and compromised diaphragmatic muscle performance (Orozco-
Levi et al., 2001; Debska et al., 2002; Kim et al., 2008). The
provision of supplemental oxygen is effective for managing
patients’ symptoms, but reoxygenation can exacerbate reactive
oxygen species (ROS) production, leading to further muscle
damage by impairing contractility and accelerating fatigue
(Debska et al., 2002; Stoller et al., 2010; Tang et al., 2013; Zuo et al.,
2014b, 2015b; Steinbacher and Eckl, 2015).
In wild-type mice, PO2 cycling/hypoxic preconditioning
(HPC) exhibits a protective effect on diaphragmatic skeletal
muscle by reducing intracellular ROS production during both
hypoxia and reoxygenation, as well as improving muscle function
(Zuo et al., 2015a,b). It is likely that HPC triggers upstream
mediators such as intracellular ROS, phosphoinositide 3-kinase
(PI3K), protein kinase B (Akt), and extracellular signal regulated
kinase (ERK). HPC also potentially facilitates the opening of
mitochondrial ATP-sensitive potassium channels (mitoKATP)
and the closure of mitochondrial permeability transition
pores (mPTP) (Zuo et al., 2015b). Likewise, in a neonatal
hypoxic-ischemic brain injury model, mitoKATP were involved
in HPC-induced neuroprotection, and the administration of
a mitoKATP channel blocker inhibited this protection (Sun
et al., 2015). In addition, mPTP inhibitor has been shown
to reduce ischemia-reperfusion (I/R)-induced skeletal muscle
damage (Garbaisz et al., 2014). However, the protective effects of
HPC and the underlying mechanisms have not been investigated
in an aged model of COPD.
Chronic obstructive pulmonary diseases is a late-onset disease
primarily found in middle aged and elderly population (Peruzza
et al., 2003). It was estimated that 16% of individuals at an age
over 65 are affected by COPD. Moreover, COPD that occurs
at a later age is linked with significantly reduced quality of life
and a higher morbidity (Peruzza et al., 2003). However, there
is currently no research that explores the potential benefits of
HPC in elderly COPD patients. Therefore, in this study, we
aimed to investigate HPC effects in an aged COPD-like mouse
model during reoxygenation. We used mice with overexpression
of pulmonary tumor necrosis factor-α (TNF-α; Tg+) that develop
emphysematous alterations (Lundblad et al., 2005; Fujita et al.,
2016). Multiple studies have indicated that TNF-α overexpression
is necessary to promote the disease (Churg et al., 2004; Lundblad
et al., 2005). Elevated expression of pulmonary TNF-α also lead
to skeletal muscle dysfunction and increased ROS generation in
contracting muscles, as commonly seen in COPD (Man et al.,
2009; Zuo et al., 2014b). We hypothesize that HPC attenuates
muscle damage during reoxygenation by strengthening the Tg+
diaphragm muscle through intracellular signaling cascades that
involve ROS and certain mitochondrial channels.
MATERIALS AND METHODS
Animals and Muscle Strip Preparation
Adult transgenic mice overexpressing pulmonary TNF-α with
the control of surfactant protein (SP)-C were produced by
crossing male SP-C/TNF-α Tg+ (a generous gift from Dr. I. Mark
Olfert, West Virginia University School of Medicine) mice with
female C57BL/6 mice followed by PCR screening to confirm
genotype (Thomson et al., 2012; Zuo et al., 2014b). All procedures
involving animals were completed in strict accordance with the
Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health, and the protocol was approved by The Ohio
State University Institutional Animal Care and Use Committee.
Male Tg+ mice aged an average of ∼20 mo (∼20–30 g body
weight) were intraperitoneally anesthetized with a mixture of
ketamine (80 mg/kg) and xylazine (10 mg/kg). The diaphragm
was quickly removed and two muscle strips (∼0.5 cm wide)
were dissected out from each leaflet of the diaphragm. Muscle
strips were obtained from a similar position of each diaphragm
to ensure a similar muscle fiber-type distribution between the
muscle strips (Figure 1A). The isolated muscle strips were
mounted in a contracting chamber filled with oxygenated Ringer’s
solution (121 mM NaCl, 21 mM NaHCO3, 11.5 mM glucose,
5.9 mM KCl, 2.0 mM CaCl2, 1.2 mM NaH2PO4, 1.0 mM MgCl2,
and 0.9 mM Na2SO4; 21◦C; pH 7.4) (Zuo et al., 2015b). Older
mice were used in this study in order to simulate elderly or severe
COPD patients who have suffered from extended periods of
breathing difficulties due to diaphragm dysfunction and require
the use of supplemental oxygen, granting clinical potentials of
HPC in this population.
Muscle Function Experiment With
Mediators
In order to determine potential signaling mediators
involved in the HPC pathway during reoxygenation, various
inhibitors/activators were administered to muscle strips. The
muscle strips were incubated in oxygenated Ringer’s solution
with respective inhibitors for 30 min prior to HPC treatment or
equilibrium (Zuo et al., 2015b): antioxidants, N-acetyl cysteine
(NAC; 1 mM; Sigma) and Tiron (O2•− scavenger; 1 mM;
Sigma) (Mohanraj et al., 1998); PI3K inhibitor (LY294002;
100 µM; EMD Millipore Corporation) (Dogra et al., 2006);
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FIGURE 1 | (A) Schematic showing that two muscle strips were dissected out from each mouse diaphragm. Lines represent the position where the diaphragm was
cut to make muscle strips. (B) Schematic showing hypoxia-reoxygenation protocol. Representative curves demonstrating the percentage of maximal force during
reoxygenation. (C) Tg+ muscle vs. (D) Tg+ muscle + HPC.
Akt inhibitor (MK-2206; 50 µM; Selleck Chemicals) (Sharma
et al., 2012); ERK inhibitor (PD98059; 100 µM; Promega)
(Ryder et al., 2000a); mPTP opener, carboxyatractyloside (CAR;
50 µM; Sigma) (Malekova et al., 2007); mPTP opening inhibitor,
cyclosporin A (100 µM; Cell Signaling Technology) (Pottecher
et al., 2013); KATP channel opening inhibitor, glibenclamide
(100 µM; Sigma) (Flagg et al., 2010); and mitoKATP channel
opener, diazoxide (100 µM; Sigma) (Flagg et al., 2010) at 21◦C.
All inhibitors/mediators were prepared in DMSO except for
antioxidants, NAC and Tiron, which were dissolved in deionized
water according to manufacture’s protocols. After 30 min of
incubation, muscle strips were washed once and preserved in
fresh Ringer’s solution without the addition of drugs. The muscle
strips were then subjected to HPC (alternating 2-min exposures
of 95 N2-5% CO2 and 95% O2-5% CO2 for five times; 20 min
total), in accordance with the previous study (Roberts et al.,
2013). These acute low oxygen (95% N2) and hyperoxic (95%
O2 ∼722 mmHg) ex vivo conditions were utilized to ensure
sufficient cellular levels of hypoxia and reoxygenation in our
settings, which could have been affected by diffusion distance in
the mouse diaphragm due to its thickness and potential leakage
of gas from the non-sealed contraction chamber (Zuo et al.,
2015b). For the two groups treated either with cyclosporin A
or diazoxide, muscles were equilibrated in Ringer’s solution
bubbled with 95% O2-5% CO2 for 20 min instead of HPC. The
Tg+ control group followed the same protocol in the absence
of inhibitor (replaced by Ringer’s solution) or HPC treatment
(Figure 1B).
The muscle strips were then exposed to 30-min hypoxia
(95 N2-5% CO2) followed by 15-min reoxygenation (95%
O2-5% CO2). Continuous stimulation of muscle strips for
5 min to measure contractile force were introduced during
15–20 min of the hypoxic and 10–15 min of the reoxygenation
periods (Figure 1B). Ringer’s solutions were maintained at
37◦C (normal human body temperature) during all muscle
contraction measurements. Measured force was normalized by
the maximal contraction during the equilibrium before HPC
treatment and after 30-min incubation with mediators in order
to minimize any potential confounding effects introduced by
individual mice variations (Figure 1B). A myograph (model
800MS; Danish Myo Technology, Aarhus, Denmark) was used
to measure muscle function, as described in the previous studies
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(Mohanraj et al., 1998; Zuo et al., 2011). Prior to initial testing,
each muscle strip was stretched to attain maximal force of
contractions using a mobile lever arm. Muscle contractile force
was determined by a stationary force transducer (force range
0–1,600 mN), which was calibrated to convert electrical voltage
to tension development per gram. The muscle was electrically
stimulated (S48 stimulator, Grass Technologies, West Warwick,
RI) with square-wave electrical pulses (0.2-ms pulse period,
250-ms train duration, 70 Hz, at 30 V). A converter (model
ML826; AD Instruments, Colorado Springs, CO, United states)
then translated these tetanic contractions into digital data for the
interpretation in LabChart 7.3.7 analyzing software.
Statistics
One-way ANOVA was used to analyze the data for statistical
significance, and was expressed sequentially as means +/− SE
(IBM SPSS Statistics 21). Post-ANOVA contrast analyses from
IBM SPSS software was used to identify differences between
treatments. p < 0.05 was considered statistically significant for
paired or independent sample t-tests, in comparison of same
group samples or differing group samples, respectively. A sample
size of five mice per group was determined using G∗Power
version 3.1.6 that can provide 80% power to detect an effect size
of 0.25 at a significance level of 0.05 based upon our previous data
on wild-type mice.
RESULTS
As shown in Figures 1C,D, HPC treatment considerably reduced
diaphragm muscle function decline during reoxygenation in Tg+
mice. Further, the percentage of maximal force in the Tg+ +
HPC group was markedly higher than the Tg+ control group
at each subsequent time point (0–5 min) during reoxygenation,
suggesting that HPC improves muscle function (n = 5, p < 0.01
for 1–5 min contraction; Figure 2).
Representative reoxygenation curves displaying the
percentage of maximal contractile force with respective
FIGURE 2 | Averaged data illustrating the force decline during the 5-min
contractile period under reoxygenation from muscles of Tg+ mouse (n = 6) vs.
Tg+ mouse + HPC (n = 5). ∗Significant different from Tg+, p < 0.05.
inhibitors/activators are depicted in Figure 3. The effects
of HPC in improving muscle function were obliterated
after incubation with (1) antioxidants (Tiron and NAC) in
Figure 3C; (2) non-mitochondrial inhibitors (PI3K inhibitor,
LY294002; ERK inhibitor, PD98059; AKT inhibitor, MK-2206) in
Figures 3D–F; and (3) mitochondrial mediators (glibenclamide
+ carboxyatractyloside) in Figure 3I. Muscle strips incubated
with either diazoxide or cyclosporin A individually demonstrated
improved contraction force comparable to the HPC curve
(Figures 3G,H, respectively). Diazoxide and cyclosporin A are
potent mitoKATP channel opener and mPTP closer, respectively,
which are both commonly used in studies investigating the
signaling cascade underlying protection associated with ischemic
preconditioning (Pain et al., 2000; Hausenloy et al., 2004; Hanley
and Daut, 2005). Similarly, our previous study using diazoxide
or cyclosporin A reported that HPC protective effects involve
the closure of mPTP and the opening of mitoKATP channels
in wild-type muscles (Zuo et al., 2015b). Our data show that
both diazoxide and cyclosporin A treatment generates similar
beneficial effects to that from HPC, suggesting the potential
involvement of mitoKATP channel and mPTP in HPC-initiated
effects.
Grouped data summarizing the percentage of the maximal
force at initial and end contraction during reoxygenation with
different inhibitors or mediators are displayed in Figures 4A,B.
The results confirmed that the Tg+ muscles can be significantly
strengthened during reoxygenation after treating with HPC
(n = 5; p = 0.004 for the 1st contraction; p = 0.005 for the end
contraction), diazoxide n = 5; p = 0.004 for the 1st contraction;
p = 0.006 for the end contraction), or cyclosporin A (n = 5;
p = 0.01 for the 1st contraction; p = 0.000 for the end contraction).
In Figure 4B, exposure to either diazoxide or cyclosporin A
alone produced similar significance in muscle function as HPC.
The normalized initial and end contractile forces increased
compared to the control (n = 5; p = 0.004 for the 1st contraction;
p = 0.005 for the end contraction). Non-mitochondrial signaling
inhibitors and mitochondrial mediators (glibenclamide +
carboxyatractyloside) diminished HPC-induced improvement
in muscle function (Figure 4). Notably, muscle treated with
glibenclamide + carboxyatractyloside resulted in contractile
force significantly lower than control (Figure 4B; n = 7, p = 0.024
for the 1st contraction; p = 0.009 for the end contraction).
DISCUSSION
Our ex vivo results show that diaphragm muscle function during
reoxygenation was significantly improved after HPC treatment
in aged Tg+ mice. Using specific inhibitors and mitochondrial
mediators, we have identified the potential HPC pathways, which
may involve the activation of ROS, PI3K, Akt, ERK, as well as the
triggering of mitoKATP channel opening and mPTP closure.
Role of ROS in HPC
Our previous studies on wild-type mice have similarly shown
that the diaphragmatic function can be significantly improved by
HPC during reoxygenation (Zuo and Re, 2014; Zuo et al., 2015c).
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FIGURE 3 | Representative reoxygenation curves showing percentage of force compared with baseline contraction of muscles incubated with respective
inhibitors/activators. Data represent approximate average contractile curve for each condition. (A) Tg+ control; n = 6. (B) HPC; n = 5. (C) 1 mM Tiron (antioxidant) +
1 mM NAC (antioxidant) + HPC; n = 5. (D) 100 µM LY294002 (PI3K inhibitor) + HPC; n = 6. (E) 50 µM MK-2206 (Akt inhibitor) + HPC; n = 5. (F) 100 µM PD98059
(ERK inhibitor) + HPC; n = 5. (G) 100 µM diazoxide (KATP channel); n = 5. (H) 100 µM cyclosporin A (mPTP opening inhibitor); n = 5. (I) 100 µM gliben (KATP channel
opening inhibitor) + 50 µM carb (mPTP opener) + HPC; n = 7. AKT, protein kinase B; Carb, carboxyatractyloside; ERK, extracellular signal-regulated kinases; Gliben,
glibenclamide; HPC, hypoxic preconditioning; KATP, mitochondrial ATP-sensitive potassium channel; mPTP, mitochondrial permeability transition pore; NAC,
N-acetyl cysteine; PI3K, phosphoinositide 3-kinase.
The development of muscle fatigue is known to be associated with
ATP depletion, metabolic by-product (e.g., H+ and phosphate)
accumulation, decreased myofibrillar Ca2+ sensitivity, and
oxidative stress (Powers et al., 2011; Grassi et al., 2015;
Debold, 2016). Interestingly, ROS play biphasic roles in skeletal
muscle function and are considered to be the major mediators
of preconditioning (Zuo et al., 2013a; He et al., 2016).
Specifically, studies have shown that the elevation of xanthine
oxidase (XO) contributes greatly to reoxygenation-associated
ROS accumulation (Ozyurt et al., 2006; Moylan and Reid, 2007).
An overproduction of ROS is considered as one of the
contributors of reduced muscle function and it results in lipid
peroxidation and oxidative alteration of cellular proteins thereby
leading to reoxygenation injury (Reid et al., 1992; Li and Jackson,
2002; Zuo et al., 2013b). Optimal levels of ROS are involved in
the intracellular adaptations and protection of various tissues
by preconditioning (Costa et al., 2013; Zuo et al., 2013a). Our
previous data on wild-type mice showed that HPC abolished the
increase in ROS production during hypoxia and reoxygenation
(Zuo et al., 2014a, 2015b). It is likely that this reduced level of ROS
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FIGURE 4 | Grouped data displaying the decline in diaphragmatic force (fatigue) during the 15-min reoxygenation period from Tg+ control (n = 6); HPC (n = 5); (A)
non-mitochondrial channel inhibitors [1 mM Tiron (antioxidant) + 1 mM NAC (antioxidant) + HPC (n = 5); 100 µM LY294002 (PI3K inhibitor) + HPC (n = 6); 50 µM
MK-2206 (Akt inhibitor) + HPC (n = 5); 100 µM PD98059 (ERK inhibitor) + HPC (n = 5)]; and (B) mitochondrial channel mediators [100 µM diazoxide (KATP channel,
n = 5); 100 µM cyclosporin A (mPTP opening inhibitor, n = 5); 100 µM gliben (KATP channel opening inhibitor) + 50 µM carb (mPTP opener) + HPC (n = 7)].
∗Significantly different from control (p < 0.05). Baseline contraction forces were measured before HPC treatment. AKT, protein kinase B; Carb, carboxyatractyloside;
ERK, extracellular signal-regulated kinases; Gliben, glibenclamide; HPC, hypoxic preconditioning; KATP, mitochondrial ATP-sensitive potassium channel; mPTP,
mitochondrial permeability transition pore; NAC, N-acetyl cysteine; PI3K, phosphoinositide 3-kinase.
plays a key role in triggering the protective effect of HPC as well as
lowering oxidative damage during reoxygenation. In the present
study, ROS scavenging by the exogenous antioxidants, Tiron and
NAC, attenuated the improved muscle function offered by HPC
(Figures 3C, 4A), further implying the involvement of ROS in
HPC protection.
PI3K-AKT-ERK Pathways in HPC
Moreover, in Tg+ mice models, diaphragmatic muscles treated
with any of the cell signaling inhibitors of PI3K, Akt, and
ERK showed diminished HPC effects (Figure 4A). Consistent
findings were reported in other models such as cardiac progenitor
cells, which suggest the pivotal role of PI3K, Akt, or ERK in
hypoxic protection. For example, Xu et al. (2016) observed that
LY294002 (PI3K inhibitor) eliminates the pro-survival effect of
HPC in vitro. Furthermore, in our study, 30-min incubation
with the mediators did not alter the maximal muscle contractile
force (data not shown), which suggests that the mediators
used in our experiments did not have marked influence on
muscle function in non-HPC treated muscles. In addition,
Akt and ERK activation is beneficial to skeletal muscle by
inducing increased ATP production, mitochondrial biogenesis,
and functional adaptation, which is consistent with our result
of HPC (Hawley, 2002; Berdeaux and Stewart, 2012). Muscle
contraction may increase glucose uptake via the activation of
PI3K/Akt cascades in an insulin-dependent manner (Zhou and
Dohm, 1997; Soos et al., 2001; Rose and Richter, 2005). In
the absence of insulin, PI3K/Akt signaling was probably kept
deactivated. However, HPC may activate PI3K/AKT independent
of insulin, which stimulate glucose uptake (Ryder et al., 2000b)
or regulate downstream mitochondrial channels to enhance the
muscle function. Previous studies on the ERK involvement
in muscle contraction have been focused on muscle adaptive
responses to exercise or hypoxia via the upregulation of nuclear
factor-κB (NF-κB) (Osorio-Fuentealba et al., 2009; Assaly et al.,
2011; He et al., 2016). Our data show that ERK inhibition
reduced HPC-treated muscle function during reoxygenation,
which suggests an acute effect mediated by ERK activation in
HPC-induced muscle cell protection.
MitoKATP and MPTP in HPC
Our previous study showed that HPC induces both the closure
of mPTP and the opening of mitoKATP channels in wild-type
muscles (Zuo et al., 2015b). Similar results were observed in
Tg+ muscles. Research has shown that abrupt mPTP opening,
in response to oxidative stress and mitochondrial Ca2+ overload,
is evident at the onset of reperfusion (Husainy et al., 2012;
Garbaisz et al., 2014). The application of carboxyatractyloside
to prevent mPTP closure may exacerbate the mPTP-induced
cell injury. This may explain why HPC muscles incubated with
carboxyatractyloside and glibenclamide showed significant lower
muscle function than control muscles during reoxygenation
(Figure 4B). The suppression of mPTP is crucial to retain
mitochondrial integrity and prevent cell death (Husainy et al.,
2012; Chen et al., 2015). Moreover, previous evidence has shown
that mitoKATP channel opening can be significantly activated in
ischemic heart, indicating their critical roles in muscle protection
under stress (Zhuo et al., 2005). Our data suggests that HPC
may be able to enhance such protective effects associated with
mitoKATP channel openings. ROS generated due to the activation
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of mitoKATP channels are reported to trigger preconditioning
(Lebuffe et al., 2003). It was reported that the reduction of
mitoKATP channel opening is associated with the extent of
fatigue (Garcia et al., 2009). In addition, mitoKATP channel
openings have been shown to lead to K+-specific mitochondrial
depolarization and swelling of de-energized mitochondria in rat
skeletal muscles, thereby modulating oxidative phosphorylation
(Pottecher et al., 2013).
Limitations
There are a few limitations in this study. First, due to the
need for continuous contraction, the diaphragm has high
oxidative enzyme activities, giving it greater resistance to fatigue
compared to other respiratory muscles (Polla et al., 2004). Despite
altered fiber distribution and slow energy consumption, the
diaphragm of COPD subjects produces similar isometric forces
as non-COPD subjects, suggesting that the active cross-bridges
generate greater force than those of control muscle (Polkey
et al., 1996; Stubbings et al., 2008). Second, overexpressed TNF-α
can elevate ROS production, likely contributing to HPC-related
molecular alterations (Machida et al., 2003). Thus, our future
studies will directly determine the correlations between TNF-α
levels and HPC effects. Third, diaphragm was kept at Ringer’s
solution bubbled with 95% O2 after isolation. However, this
operation can cause additional reoxygenation-related muscle
damage. The diaphragmatic muscles were stimulated for 5 min
during both hypoxic and reoxygenation periods. This tetanic
contraction during hypoxia is energetically expensive for muscles
and can lead to additional fatigue or injury, thus affecting
muscle performance during the following reoxygenation. All
these limitations can possibly create some bias in the evaluation
of reoxygenation-associated muscle function.
PERSPECTIVES AND SIGNIFICANCE
Little research has been focused on HPC or non-pharmacological
treatments of respiratory skeletal muscle during reperfusion
injuries and in the context of COPD in elderly. Here
for the first time, we demonstrate that aged Tg+
(COPD-like) skeletal muscle which has undergone HPC
sustains muscle force production and exhibits improved
muscle function during reoxygenation. A possible signaling
pathway involved in HPC protection has been proposed.
Identifying the interaction between ROS, PI3K, Akt, ERK, and
mitochondrial channels in HPC will be useful in developing
pharmacological treatment that can enhance HPC effects.
However, additional studies are needed to fully evaluate
the clinical feasibility and effectiveness of HPC in different
models.
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